Paltimatrectinib (PBI-200) is a potent tyrosine kinase inhibitor with anticancer activity that inhibits myosin-related kinase A (TrkA).Paltimatrectinib is used in the study of bladder, breast and colorectal cancers.
Molecular Weight:
434.37
Purity:
99.96%
CAS Number:
[2353522-15-1]
Formula:
C20H15F5N6
Target:
Trk receptor|||Tyrosine Kinases|||Tyrosinase
T62447
* VAT and and shipping costs not included. Errors and price changes excepted
